Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Heparanase procoagulant activity is elevated and predicts survival in non-small cell lung cancer patients.

Heparanase procoagulant activity is elevated and predicts survival in non-small cell lung cancer patients. Thromb Res. 2014 Sep; 134(3):639-42.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.